Vascular stiffness in insulin resistance and obesity

Frontiers in Physiology

Volumn 6, Issue Aug, 2015, Pages

  Jia, Guanghong ^a,b   Aroor, Annayya R ^a,b   DeMarco, Vincent G ^a,b,c   Martinez Lemus, Luis A ^b,c,d   Meininger, Gerald A ^c,d   Sowers, James R ^a,b,c,d  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cardiovascular disease; Insulin resistance; Obesity; Vascular resistance

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; C REACTIVE PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FATTY ACID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTACYCLIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADIPOSE TISSUE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; BODY MASS; CALCIUM CELL LEVEL; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR MATRIX; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; POSTMENOPAUSE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SEX DIFFERENCE; UPREGULATION;

EID: 84940988202     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00231     Document Type: Review

References (66)

1. Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A. K., Gourdy, P., Zoll, J., et al. (2006). Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178-180. doi: 10.1038/nm1343
2. Aroor, A. R., Demarco, V. G., Jia, G., Sun, Z., Nistala, R., Meininger, G. A., et al. (2013a). The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front. Endocrinol. 4:161. doi: 10.3389/fendo.2013.00161
3. Aroor, A. R., McKarns, S., Demarco, V. G., Jia, G., and Sowers, J. R. (2013b). Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 62, 1543-1552. doi: 10.1016/j.metabol.2013.07.001
4. Bender, S. B., McGraw, A. P., Jaffe, I. Z., and Sowers, J. R. (2013). Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes 62, 313-319. doi: 10.2337/db12-0905
5. Blüher, M. (2010). The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr. Opin. Lipidol. 21, 38-43. doi: 10.1097/MOL.0b013e3283346ccc
6. Bostick, B., Habibi, J., DeMarco, V. G., Jia, G., Domeier, T. L., Lambert, M. D., et al. (2015). Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice. Am. J. Physiol. Heart Circ. Physiol. 308, H1126-H1135. doi: 10.1152/ajpheart.00898.2014
7. Bostick, B., Habibi, J., Ma, L., Aroor, A., Rehmer, N., Hayden, M. R., et al. (2014). Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity. Metabolism 63, 1000-1011. doi: 10.1016/j.metabol.2014.04.002
8. Brillante, D. G., O'Sullivan, A. J., and Howes, L. G. (2009). Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors. Vasc. Health Risk Manag. 5, 73-78. doi: 10.2147/VHRM.S3784
9. Chung, A. W., Yang, H. H., Sigrist, M. K., Brin, G., Chum, E., Gourlay, W. A., et al. (2009). Matrix metalloproteinase-2 and-9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc. Res. 84, 494-504. doi: 10.1093/cvr/cvp242
10. Clayton, J. A., and Collins, F. S. (2014). Policy: NIH to balance sex in cell and animal studies. Nature 509, 282-283. doi: 10.1038/509282a
11. Cote, A. T., Harris, K. C., Panagiotopoulos, C., Sandor, G. G., and Devlin, A. M. (2013). Childhood obesity and cardiovascular dysfunction. J. Am. Coll. Cardiol. 62, 1309-1319. doi: 10.1016/j.jacc.2013.07.042
12. Cote, A. T., Phillips, A. A., Harris, K. C., Sandor, G. G., Panagiotopoulos, C., and Devlin, A. M. (2015). Obesity and arterial stiffness in children: systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 35, 1038-1044. doi: 10.1161/ATVBAHA.114.305062
13. Creager, M. A., Luscher, T. F., Cosentino, F., and Beckman, J. A. (2003). Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108, 1527-1532. doi: 10.1161/01.CIR.0000091257.27563.32
14. Deenadayalu, V., Puttabyatappa, Y., Liu, A. T., Stallone, J. N., and White, R. E. (2012). Testosterone-induced relaxation of coronary arteries: activation of BKCa channels via the cGMP-dependent protein kinase. Am. J. Physiol. Heart Circ. Physiol. 302, H115-H123. doi: 10.1152/ajpheart.00046.2011
15. DeMarco, V. G., Aroor, A. R., and Sowers, J. R. (2014). The pathophysiology of hypertension in patients with obesity. Nat. Rev. Endocrinol. 10, 364-376. doi: 10.1038/nrendo.2014.44
16. DeMarco, V. G., Habibi, J., Jia, G., Aroor, A. R., Ramirez-Perez, F. I., Martinez-Lemus, L. A., et al. (2015). Low-dose mineralocorticoid receptor blockade prevents western diet-induced arterial stiffening in female mice. Hypertension 66, 99-107. doi: 10.1161/HYPERTENSIONAHA.115.05674
17. Doronzo, G., Russo, I., Mattiello, L., Anfossi, G., Bosia, A., and Trovati, M. (2004). Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. Eur. J. Clin. Invest. 34, 664-673. doi: 10.1111/j.1365-2362.2004.01412.x
18. Fels, J., Jeggle, P., Liashkovich, I., Peters, W., and Oberleithner, H. (2014). Nanomechanics of vascular endothelium. Cell Tissue Res. 355, 727-737. doi: 10.1007/s00441-014-1853-5
19. Forte, V., Pandey, A., Abdelmessih, R., Forte, G., Whaley-Connell, A., Sowers, J. R., et al. (2012). Obesity, diabetes, the cardiorenal syndrome, and risk for cancer. Cardiorenal. Med. 2, 143-162. doi: 10.1159/000337314
20. Grobe, J. L., Rahmouni, K., Liu, X., and Sigmund, C. D. (2013). Metabolic rate regulation by the renin-angiotensin system: brain vs. body. Pflugers Arch. 465, 167-175. doi: 10.1007/s00424-012-1096-9
21. He, S., Li, M., Ma, X., Lin, J., and Li, D. (2010). CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 30, 2621-2630. doi: 10.1161/ATVBAHA.110.210492
22. Herouvi, D., Karanasios, E., Karayianni, C., and Karavanaki, K. (2013). Cardiovascular disease in childhood: the role of obesity. Eur. J. Pediatr. 172, 721-732. doi: 10.1007/s00431-013-1932-8
23. Ho, C. T., Lin, C. C., Hsu, H. S., Liu, C. S., Davidson, L. E., Li, T. C., et al. (2011). Arterial stiffness is strongly associated with insulin resistance in Chinese-a population-based study (Taichung Community Health Study, TCHS). J. Atheroscler. Thromb. 18, 122-130.
24. Hubert, H. B., Feinleib, M., McNamara, P. M., and Castelli, W. P. (1983). Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67, 968-977.
25. Jia, G., Aroor, A. R., Martinez-Lemus, L. A., and Sowers, J. R. (2014a). Overnutrition, mTOR signaling, and cardiovascular diseases. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R1198-R1206. doi: 10.1152/ajpregu.00262.2014
26. Jia, G., Aroor, A. R., and Sowers, J. R. (2014b). Arterial stiffness: a nexus between cardiac and renal disease. Cardiorenal. Med. 4, 60-71. doi: 10.1159/000360867
27. Jia, G., Aroor, A. R., Whaley-Connell, A. T., and Sowers, J. R. (2014c). Fructose and uric acid: is there a role in endothelial function? Curr. Hypertens. Rep. 16:434. doi: 10.1007/s11906-014-0434-z
28. Jia, G., Habibi, J., Bostick, B. P., Ma, L., DeMarco, V. G., Aroor, A. R., et al. (2015). Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet. Hypertension 65, 531-539. doi: 10.1161/HYPERTENSIONAHA.114.04737
29. Jia, G., and Sowers, J. R. (2014). Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk. Hypertension 64, 1192-1193. doi: 10.1161/HYPERTENSIONAHA.114.04348
30. Kaess, B. M., Rong, J., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, D., et al. (2012). Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 308, 875-881. doi: 10.1001/2012.jama.10503
31. Kamimae-Lanning, A. N., Krasnow, S. M., Goloviznina, N. A., Zhu, X., Roth-Carter, Q. R., Levasseur, P. R., et al. (2015). Maternal high-fat diet and obesity compromise fetal hematopoiesis. Mol. Metab. 4, 25-38. doi: 10.1016/j.molmet.2014.11.001
32. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., et al. (2006). MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494-1505. doi: 10.1172/JCI26498
33. Kim, J. A., Jang, H. J., Martinez-Lemus, L. A., and Sowers, J. R. (2012). Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am. J. Physiol. Endocrinol. Metab. 302, E201-E208. doi: 10.1152/ajpendo.00497.2011
34. Kusche-Vihrog, K., Jeggle, P., and Oberleithner, H. (2014). The role of ENaC in vascular endothelium. Pflugers Arch. 466, 851-859. doi: 10.1007/s00424-013-1356-3
35. Leopold, J. A. (2013). Cellular and molecular mechanisms of arterial stiffness associated with obesity. Hypertension 62, 1003-1004. doi: 10.1161/HYPERTENSIONAHA.113.01872
36. Liao, J., and Farmer, J. (2014). Arterial stiffness as a risk factor for coronary artery disease. Curr. Atheroscler. Rep. 16:387. doi: 10.1007/s11883-013-0387-8
37. Luft, F. C. (2012). Molecular mechanisms of arterial stiffness: new insights. J. Am. Soc. Hypertens. 6, 436-438. doi: 10.1016/j.jash.2012.10.004
38. Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281-1357. doi: 10.1097/01.hjh.0000431740.32696.cc
39. Manrique, C., DeMarco, V. G., Aroor, A. R., Mugerfeld, I., Garro, M., Habibi, J., et al. (2013). Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet. Endocrinology 154, 3632-3642. doi: 10.1210/en.2013-1256
40. Martínez-Martínez, E., Miana, M., Jurado-López, R., Bartolomé, M. V., Souza Neto, F. V., Salaices, M., et al. (2014). The potential role of leptin in the vascular remodeling associated with obesity. Int. J. Obes. (Lond.) 38, 1565-1572. doi: 10.1038/ijo.2014.37
41. Matsuoka, O., Otsuka, K., Murakami, S., Hotta, N., Yamanaka, G., Kubo, Y., et al. (2005). Arterial stiffness independently predicts cardiovascular events in an elderly community-Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed Pharmacother. 59(Suppl. 1), S40-S44. doi: 10.1016/S0753-3322(05)80008-3
42. Mitchell, G. F., Hwang, S. J., Vasan, R. S., Larson, M. G., Pencina, M. J., Hamburg, N. M., et al. (2010). Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121, 505-511. doi: 10.1161/CIRCULATIONAHA.109.886655
43. Morse, S. A., Gulati, R., and Reisin, E. (2010). The obesity paradox and cardiovascular disease. Curr. Hypertens. Rep. 12, 120-126. doi: 10.1007/s11906-010-0099-1
44. Mudau, M., Genis, A., Lochner, A., and Strijdom, H. (2012). Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc. J. Afr. 23, 222-231. doi: 10.5830/CVJA-2011-068
45. Oberleithner, H. (2014). Vascular endothelium: a vulnerable transit zone for merciless sodium. Nephrol. Dial. Transplant. 29, 240-246. doi: 10.1093/ndt/gft461
46. Padilla, J., Vieira-Potter, V. J., Jia, G., and Sowers, J. R. (2015). Role of perivascular adipose tissue on vascular reactive oxygen species in type 2 diabetes: a give-and-take relationship. Diabetes 64, 1904-1906. doi: 10.2337/db15-0096
47. Paik, J. K., Kim, M., Kwak, J. H., Lee, E. K., Lee, S. H., and Lee, J. H. (2013). Increased arterial stiffness in subjects with impaired fasting glucose. J. Diabetes Complications 27, 224-228. doi: 10.1016/j.jdiacomp.2012.10.012
48. Ray, S., Miglio, C., Eden, T., and Del Rio, D. (2014). Assessment of vascular and endothelial dysfunction in nutritional studies. Nutr. Metab. Cardiovasc. Dis. 24, 940-946. doi: 10.1016/j.numecd.2014.03.011
49. Reference Values for Arterial Stiffness Collaboration (2010). Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur. Heart J. 31, 2338-2350. doi: 10.1093/eurheartj/ehq165
50. Salomaa, V., Riley, W., Kark, J. D., Nardo, C., and Folsom, A. R. (1995). Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 91, 1432-1443.
51. Santos, S. H., Fernandes, L. R., Mario, E. G., Ferreira, A. V., Pîrto, L. C., Alvarez-Leite, J. I., et al. (2008). Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 57, 340-347. doi: 10.2337/db07-0953
52. Schiffrin, E. L. (2004). Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Am J Hypertens. 17, 39S-48S. doi: 10.1016/j.amjhyper.2004.08.019
53. Selcuk, A., Bulucu, F., Kalafat, F., Cakar, M., Demirbas, S., Karaman, M., et al. (2013). Skinfold thickness as a predictor of arterial stiffness: obesity and fatness linked to higher stiffness measurements in hypertensive patients. Clin. Exp. Hypertens. 35, 459-464. doi: 10.3109/10641963.2012.746357
54. Sowers, J. R. (2013). Diabetes mellitus and vascular disease. Hypertension 61, 943-947. doi: 10.1161/HYPERTENSIONAHA.111.00612
55. Strasser, B., Arvandi, M., Pasha, E. P., Haley, A. P., Stanforth, P., and Tanaka, H. (2015). Abdominal obesity is associated with arterial stiffness in middle-aged adults. Nutr. Metab. Cardiovasc. Dis. 25, 495-502. doi: 10.1016/j.numecd.2015.01.002
56. Thanassoulis, G., Massaro, J. M., Corsini, E., Rogers, I., Schlett, C. L., Meigs, J. B., et al. (2012). Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J. Am. Heart Assoc. 1:e000885. doi: 10.1161/JAHA.112.000885
57. Torjesen, A. A., Sigurethsson, S., Westenberg, J. J., Gotal, J. D., Bell, V., Aspelund, T., et al. (2014). Pulse pressure relation to aortic and left ventricular structure in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. Hypertension 64, 756-761. doi: 10.1161/HYPERTENSIONAHA.114.03870
58. Tounian, P., Aggoun, Y., Dubern, B., Varille, V., Guy-Grand, B., Sidi, D., et al. (2001). Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 358, 1400-1404. doi: 10.1016/S0140-6736(01)06525-4
59. Tsai, T. H., Chai, H. T., Sun, C. K., Yen, C. H., Leu, S., Chen, Y. L., et al. (2012). Obesity suppresses circulating level and function of endothelial progenitor cells and heart function. J. Transl. Med. 10:137. doi: 10.1186/1479-5876-10-137
60. van Popele, N. M., Elizabeth Hak, A., Mattace-Raso, F. U., Bots, M. L., van der Kuip, D. A., Reneman, R. S., et al. (2006). Impaired fasting glucose is associated with increased arterial stiffness in elderly people without diabetes mellitus: the Rotterdam Study. J. Am. Geriatr. Soc. 54, 397-404. doi: 10.1111/j.1532-5415.2005.00614.x
61. Vasan, R. S., Evans, J. C., Benjamin, E. J., Levy, D., Larson, M. G., Sundstrom, J., et al. (2004). Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 43, 957-962. doi: 10.1161/01.HYP.0000124251.06056.8e
62. Villacorta, L., and Chang, L. (2015). The role of perivascular adipose tissue in vasoconstriction, arterial stiffness, and aneurysm. Horm. Mol. Biol. Clin. Investig. 21, 137-147. doi: 10.1515/hmbci-2014-0048
63. Wang, M., Jiang, L., Monticone, R. E., and Lakatta, E. G. (2014). Proinflammation: the key to arterial aging. Trends Endocrinol. Metab. 25, 72-79. doi: 10.1016/j.tem.2013.10.002
64. Weisbrod, R. M., Shiang, T., Al Sayah, L., Fry, J. L., Bajpai, S., Reinhart-King, C. A., et al. (2013). Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension 62, 1105-1110. doi: 10.1161/HYPERTENSIONAHA.113.01744
65. Zapolski, T., Wacinski, P., Kondracki, B., Rychta, E., Buraczynska, M. J., and Wysokinski, A. (2011). Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. Kardiol. Pol. 69, 319-326.
66. Zhou, R. H., Vendrov, A. E., Tchivilev, I., Niu, X. L., Molnar, K. C., Rojas, M., et al. (2012). Mitochondrial oxidative stress in aortic stiffening with age: the role of smooth muscle cell function. Arterioscler. Thromb. Vasc. Biol. 32, 745-755. doi: 10.1161/ATVBAHA.111.243121